
The Medicines and Healthcare products Regulatory Agency (MHRA) has announced that two investigational medicines targeting liver cancer and dementia with …
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

